Previous Article | Next Article ![]()
Journal of Clinical Microbiology, November 2002, p. 3942-3950, Vol. 40, No. 11
0095-1137/02/$04.00+0 DOI: 10.1128/JCM.40.11.3942-3950.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
Grupo de Microbiologia, Instituto Nacional de Salud, Bogotá, Colombia,a Unidad de Microbiologia, Departamento de Laboratorios, Ministerio de Salud, Montevideo Uruguay2
Received 10 July 2002/ Accepted 7 August 2002
Streptococcus pneumoniae serotype 5 is the third most common capsular type causing invasive diseases in children younger than 5 years in Latin America. Preliminary data on Colombian serotype 5 isolates indicated a common clonal origin associated with resistance to tetracycline (TET) and chloramphenicol (CHL). We studied 172 S. pneumoniae serotype 5 invasive isolates from Argentina, Brazil, Colombia, Guatemala, Mexico, and Uruguay and confirmed the presence of the Colombia5-19 clone throughout Latin America. Fifteen subtypes of a pulsed-field gel electrophoresis pattern and 4 electrophoretic types (ET) were obtained. Most of the isolates from different geographical regions belonged to pattern A (34.3%), subtype A5 (41.9%), and ET1 (91.1%). The A pattern (n = 59) was resistant to TET and had variable resistance to CHL; it was present in Brazil (10.2%), Colombia (78%), Guatemala (8.5%), and Mexico (3.4%). Subtype A5 with variable susceptibility to TET and sensitive to CHL was found in Argentina (29.2%), Mexico (8.3%), and Uruguay (62.5%). Subtypes A1-A4, A7-A8, and A9-A11 (closely related to A) also shared ET1, while subtype A6 was assigned to ET1, ET2, and ET3. Eleven subtypes (n = 21) were found to be specific for one country each. In summary, the S. pneumoniae serotype 5 isolates from Latin American are genetically closely related but show different patterns of antibiotic resistance, probably as a result of horizontal transfer.
Sireva-Vigia Working Group: Gabriela Echániz-Aviles, Instituto Nacional de Salud Pública, Cuernavaca, México; Maria Cristina C. Brandileone, Instituto Adolfo Lutz, São Paulo, Brazil; Mabel Regueira, Instituto de Microbiologia Carlos Malbrán, Buenos Aires, Argentina; Edwin J. Asturias, Center for Disease Studies and Control, Guatemala, and Johns Hopkins Bloomberg School of Public Health, Baltimore, Md.; José Luis Di Fabio, Pan American Health Organization, Washington, D.C.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»